Home›Stock Screener›Bilcare

Bilcare Share Price Today | Stock Price & Bilcare Share Screener

BI Healthcare Services
Live Share Price NSE
₹76.84
▼ -3.54 (-4.40%)
2026-11-20 00:00:00
Live Share Price BSE
₹76.91
▼ -3.13 (-3.91%)
2026-11-20 00:00:00

As of November 20, 2026, the live Bilcare share price (NSE: BI) is ₹76.84 on NSE and ₹76.91 on BSE, down 4.40% from the previous close, with shares trading between ₹76.40 and ₹81.60 in today's trading session, and a 52-week range of ₹56.18–₹101.38. Track Bilcare market worth to gauge the company's total market size. Use the Bilcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Bilcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹252 and net income of ₹1, with EBITDA of ₹26, an operating margin of 9.0% and a profit margin of 0.4%.

Bilcare Market Cap ₹197.54 Cr.
BI P/E Ratio (TTM) 10.90
Bilcare P/B Ratio 1.09
EPS (TTM) ₹0.73
Dividend Yield -
Debt to Equity 3.19
BI 52 Week High ₹101.38
Bilcare 52 Week Low ₹56.18
Operating Margin 9.00%
Profit Margin 0.40%
BI Revenue (TTM) ₹252.00
EBITDA ₹26.00
Net Income ₹1.00
Total Assets ₹843.00
Total Equity ₹74.00

Bilcare Share Price Chart

Track the current stock price of Bilcare with an interactive chart. Analyse BI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Bilcare stock quote in one place.

The quote of ₹76.84 sits between the 52-week low of ₹56.18 and the 52-week high of ₹101.38, and the latest session moved -4.40% from the previous close.

Bilcare Company Profile - Fundamental Screener

Screen Bilcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE986A01012.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE986A01012

Bilcare Balance Sheet Screener

Screen BI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹843, down from ₹924 in 2025.

Latest statistics put total assets at ₹843 and shareholder funds at ₹74, with a leverage ratio of 3.19.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 843 924 1,568 1,593 1,127 1,064 1,112 3,159 3,479 3,507
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 432 456 1,038 1,046 465 494 534 2,006 2,180 2,403

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 477 495 572 551 563 586 624 1,096 1,037 2,085
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 74 90 646 704 161 164 176 -6 463 676
Share Capital 24 24 24 24 24 24 24 24 24 24
Reserves & Surplus 173 191 474 507 52 63 85 -93 376 590

Bilcare Income Statement Screener - Profit & Revenue Analysis

Screen Bilcare income statement and profit fundamentals. Analyze BI quarterly results. Bilcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹252 and net profit was ₹1, equal to earnings per unit of ₹1.75, at an operating margin of 9%.

In that period expenses were ₹226, interest cost ₹20 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹228 and net profit of ₹15.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun

Revenue and Expenses

Revenue 252 228 202 187 183 192 215 202 206 198 198 209 179 200 186
Expenses 226 191 173 170 175 175 186 197 204 175 175 208 158 183 170

Operating Costs and Margins

EBITDA 26 37 29 16 8 17 29 4 2 23 23 1 21 17 16
Operating Profit % 9.00% 16.00% 8.00% 6.00% 2.00% 6.00% 4.00% 0.00% -1.00% 10.00% 10.00% -4.00% 10.00% 4.00% 7.00%
Depreciation 4 4 5 5 5 12 5 12 11 12 12 13 11 11 11
Interest 20 18 18 17 19 19 19 20 24 21 21 23 21 20 19

Profit and Earnings

Profit Before Tax 2 15 7 -6 -17 -13 6 -27 -33 -10 -10 -35 -10 -13 -13
Tax 1 0 -1 0 0 -3 -7 -11 -3 5 5 -16 3 -1 0
Net Profit 1 15 8 -6 -16 -10 12 -16 -30 -15 -15 -20 -14 -12 -13
EPS 1.75 5.39 5.68 0.41 -2.31 -1.61 7.47 -3.05 -6.81 -2.71 -2.71 -4.63 -2.91 -3.22 -3.36

Bilcare Cash Flow Screener - Liquidity Fundamentals

Screen BI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹128, and net cash flow was an outflow of ₹10.

Over the same period, investing activities used ₹5 and financing activities used ₹132.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 128 86 63 -7 41 72 256 206 99 300
Investing Activities -5 81 -106 36 -4 2 1,309 -104 -203 -129

Financing and Net Cash

Financing Activities -132 -171 36 -19 -55 -83 -1,600 -103 91 -155
Net Cash Flow -10 -3 -8 10 -18 -9 -35 -1 -13 16

Bilcare Shareholding Pattern Screener

See Bilcare shareholding pattern with promoter, FII, and DII holdings. Check Bilcare promoter holding and ownership changes for BI on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 30.01%, foreign institutions 0.04%, domestic institutions 0.00% and the public 45.33%, spread across 15,584 shareholders.

The shareholder count was 15,584 in 2026-Sept, compared with 15,777 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01%

Institutional Investors

FII Holding 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 45.33% 45.32% 45.18% 45.45% 45.40% 44.96% 44.68% 45.40%
Other Holding 24.61% 24.62% 24.76% 24.49% 24.54% 24.99% 25.26% 24.55%
Shareholder Count 15,584 15,777 15,824 16,068 16,513 17,047 17,586 18,496

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Bilcare. Bilcare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Bilcare.

Bilcare Stock Index Membership - Nifty & Sensex

See which indices include Bilcare stock. Check BI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Bilcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Bilcare Market Events Screener - Corporate Actions

Get Bilcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Bilcare stock events that may affect BI share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2026, with a record date of November 3, 2026.

It is followed by Annual General Meeting dated September 26, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-03 2026-11-03 Quarterly Result Announcement NA -1.75%
2026-09-26 2026-09-26 Annual General Meeting NA 14.35%
2026-08-13 2026-08-13 Quarterly Result Announcement NA 5.28%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -1.29%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 2.30%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -5.12%
2025-09-24 2025-09-24 Annual General Meeting NA 31.15%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -1.45%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -0.20%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -13.94%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -5.03%
2024-09-27 2024-09-27 Annual General Meeting NA -7.47%

Bilcare Competitors Screener - Peer Stocks Comparison

Screen BI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 125,021 52.40 25,420 15.58% 2,003 57.80
Max Healthcare Institute 97,015 66.60 8,536 18.82% 1,442 62.55
Manipal Health Enterprises 87,598 98.70 10,521 25.80% 917 55.29
Aster DM Quality Care 64,517 111.60 4,769 11.25% 427 54.92
Fortis Healthcare 59,608 54.40 9,179 16.93% 1,064 46.04
Global Health 38,986 63.80 4,509 19.56% 554 68.03
Narayana Hrudayalaya 38,334 44.30 7,996 43.43% 811 56.24
Dr. Lal Path Labs 33,914 56.90 2,864 12.11% 510 56.83
Krishna Institute of Medical Sciences 31,257 155.60 3,931 28.16% 242 54.48
Syngene International 17,905 96.50 3,809 2.56% 317 68.00

Bilcare Company Announcements - News & Reports Screener

Screen BI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 12, 2026.

The next most recent announcements are dated November 3, 2026 and November 3, 2026.

Date Update Actions
2026-11-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-03 Results - Financial Results For September 30 2026 -
2026-11-03 Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2026 Along With Limited Review Reports And Change In Designation And Roles -
2026-10-27 Board Meeting Intimation for For Un-Audited Financial Results For The Period Ended On 30 September 2026 -
2026-10-19 Announcement Under Regulation 30(LODR) - Update On Voluntary Winding Up Of Bilcare INC US -
2026-10-15 Announcement under Regulation 30 (LODR)-Change in Management -
2026-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-29 Voting Results Of 39Th Annual General Meeting And Scrutinizers Report -
2026-09-28 Closure of Trading Window -
2026-09-26 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-24 Corrigendum To Notice Of The 39Th Annual General Meeting -
2026-09-24 Corrigendum To Notice Of The 39Th Annual General Meeting -
2026-09-21 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-04 Board Meeting Outcome for Outcome Of Board Meeting -
2026-09-04 Reg. 34 (1) Annual Report. -
2026-09-04 Annual Report - 2025-26 -
2026-08-22 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-15 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Voluntary Winding Up Of Wholly Owned Subsidiary -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹76.84, within a 52-week range of ₹56.18 to ₹101.38. The P/E ratio is 10.90 and the P/B ratio is 1.09, with earnings per unit of ₹0.73. Market capitalisation stands at ₹197.54 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 22, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.